These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31239251)

  • 21. Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol.
    Larsson A; Hagström E; Nilsson L; Svensson MK
    Ups J Med Sci; 2018 Jun; 123(2):94-99. PubMed ID: 29745278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of including C-reactive protein in cardiovascular risk prediction models for women.
    Cook NR; Buring JE; Ridker PM
    Ann Intern Med; 2006 Jul; 145(1):21-9. PubMed ID: 16818925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.
    Carter NJ
    Am J Cardiovasc Drugs; 2010; 10(6):383-400. PubMed ID: 21090831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults.
    Takeuchi T; Nemoto K; Takahashi O; Urayama KY; Deshpande GA; Izumo H
    J Clin Lipidol; 2014; 8(5):501-9. PubMed ID: 25234563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors.
    Pihl E; Zilmer K; Kullisaar T; Kairane C; Pulges A; Zilmer M
    Atherosclerosis; 2003 Dec; 171(2):321-6. PubMed ID: 14644403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA study.
    Sone H; Nakagami T; Nishimura R; Tajima N;
    Diabetes Res Clin Pract; 2016 Mar; 113():14-22. PubMed ID: 26972955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P
    Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort.
    Shemesh T; Rowley KG; Jenkins AJ; Best JD; O'Dea K
    Clin Chem; 2009 Feb; 55(2):336-41. PubMed ID: 19074519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly.
    Nadrowski P; Chudek J; Skrzypek M; Puzianowska-Kuźnicka M; Mossakowska M; Więcek A; Zdrojewski T; Grodzicki T; Kozakiewicz K
    Exp Gerontol; 2016 Dec; 85():112-117. PubMed ID: 27729238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.
    Glynn RJ; MacFadyen JG; Ridker PM
    Clin Chem; 2009 Feb; 55(2):305-12. PubMed ID: 19095726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.
    Pikula A; Beiser AS; Wang J; Himali JJ; Kelly-Hayes M; Kase CS; Yang Q; Seshadri S; Wolf PA
    Neurology; 2015 Feb; 84(5):472-9. PubMed ID: 25568296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Influence of Triclosan on Biomarkers of Cardiovascular Risk in Patients in the Cardiovascular and Periodontal Study (CAPS): A Randomized Controlled Trial.
    Cullinan MP; Palmer JE; Faddy MJ; Westerman B; Carle AD; West MJ; Seymour GJ
    J Periodontol; 2015 Jul; 86(7):847-55. PubMed ID: 25741582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status.
    Liu X; Yang Y; Kang F; Li J; Zhou M; Ma X; Yu T; Zhang T; Xue F
    Am J Cardiol; 2019 Sep; 124(5):702-708. PubMed ID: 31311663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines.
    Mora S; Musunuru K; Blumenthal RS
    Clin Chem; 2009 Feb; 55(2):219-28. PubMed ID: 19095730
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.